RecruitingNot ApplicableNCT05622344

StableEyes With Active Neurofeedback

StableEyes With Active Neurophysiological Feedback


Sponsor

Johns Hopkins University

Enrollment

48 participants

Start Date

Aug 8, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.


Eligibility

Min Age: 21 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called SWAN and a behavioral approach called Traditional Therapy for people with motion sickness, space motion sickness, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 21 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTraditional Therapy

Exercises that teaches subjects to move their heads while viewing still or moving targets.

DEVICESWAN

The SWAN device uses video-oculography to monitor head motion while guiding participants to move their head in yaw, pitch, roll planes for 15 minutes. Feedback is provided regarding frequency and plane of head rotation


Locations(2)

Johns Hopkins University

Baltimore, Maryland, United States

Naval Medical Research Unit

Dayton, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05622344


Related Trials